Addus HomeCare (NASDAQ:ADUS) Downgraded by StockNews.com to "Hold"

Addus HomeCare (NASDAQ:ADUS - Get Free Report) was downgraded by equities research analysts at StockNews.com from a "buy" rating to a "hold" rating in a research report issued on Wednesday.

Several other analysts also recently commented on ADUS. Citizens Jmp raised Addus HomeCare to a "strong-buy" rating in a research note on Monday, December 16th. Oppenheimer increased their price objective on Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Royal Bank of Canada reissued an "outperform" rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. Macquarie reaffirmed an "outperform" rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. Finally, JMP Securities initiated coverage on Addus HomeCare in a research report on Monday, December 16th. They set an "outperform" rating and a $150.00 price target for the company. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $132.78.

Addus HomeCare Trading Down 1.0 %

ADUS stock traded down $0.98 during trading on Wednesday, reaching $95.77. 247,318 shares of the stock were exchanged, compared to its average volume of 143,296. The firm's 50 day moving average is $121.89 and its 200 day moving average is $125.85. Addus HomeCare has a twelve month low of $87.88 and a twelve month high of $136.72. The firm has a market cap of $1.74 billion, a P/E ratio of 21.92, a price-to-earnings-growth ratio of 1.41 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The firm had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. As a group, analysts predict that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares of the company's stock, valued at approximately $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R Dirk Allison sold 25,000 shares of the firm's stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now directly owns 79,397 shares of the company's stock, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Addus HomeCare

A number of large investors have recently made changes to their positions in ADUS. Quarry LP bought a new position in shares of Addus HomeCare in the third quarter worth $28,000. Natixis boosted its holdings in shares of Addus HomeCare by 111.9% in the fourth quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after acquiring an additional 132 shares during the period. Smartleaf Asset Management LLC boosted its holdings in shares of Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after acquiring an additional 214 shares during the period. Farther Finance Advisors LLC boosted its holdings in shares of Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock worth $49,000 after acquiring an additional 366 shares during the period. Finally, Parkside Financial Bank & Trust boosted its holdings in shares of Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after acquiring an additional 148 shares during the period. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.